SEEL - Seelos falls as lead drug fails in ALS trial
2024-03-19 09:09:46 ET
More on Seelos Therapeutics
- Seelos Therapeutics files for 3.4M shares secondary offering
- Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation
- Seeking Alpha’s Quant Rating on Seelos Therapeutics
- Historical earnings data for Seelos Therapeutics
- Financial information for Seelos Therapeutics